Achieving asthma control in patients with moderate disease

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 2, 2010, Pages 307-311

  FitzGerald, J Mark ^a   Shahidi, Neal ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; FORMOTEROL; LANSOPRAZOLE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; ZAFIRLUKAST;

ADD ON THERAPY; ARTICLE; ASTHMA; CLINICAL TRIAL; DISEASE CONTROL; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG MEGADOSE; ENVIRONMENTAL FACTOR; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL REFLUX; HEART ARRHYTHMIA; HUMAN; LOW DRUG DOSE; NAUSEA; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; SLEEP DISORDER; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; VOMITING;

ANTI-ASTHMATIC AGENTS; ASTHMA; CLINICAL TRIALS AS TOPIC; HUMANS; PATIENT EDUCATION AS TOPIC;

EID: 75849151413     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.12.978     Document Type: Article

References (34)

1. Bahadori K., Doyle-Waters M., Marra C., Lynd L., Alasaly K., Swiston J., et al. Economic burden of asthma: a systematic review. BMC Pulm Med 9 (2009) 24
2. Ducharme F., and di Salvio F. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev 1 (2004) CD002314
3. Oborne J., Mortimer K., Hubbard R.B., Tattersfield A.E., and Harrison T.W. Quadrupling the dose of inhaled corticosteroids to prevent asthma exacerbation: a randomized, double blind, placebo controlled, parallel-group clinical trial. Am J Respir Crit Care Med 180 (2009) 598-602
4. Gibson P.G., Powell H., Wilson A., Abramson M.J., Haywood P., Bauman A., et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 3 (2002) CD001117
5. Gibson P.G., Powell H., Wilson A., Hensley M.J., Abramson M.J., Bauman A., et al. Limited (information only) patient education programs for adults with asthma. Cochrane Database Syst Rev 1 (2002) CD001005
6. Littner M.R., Leung F.W., Ballard II E.D., Huang B., Samra N.K., and on behalf of the lansoprazole asthma study group. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatics patients with acid reflux symptoms. Chest 128 (2005) 1128-1135
7. Donahue J.G., Weiss S.T., Livingston J.M., Goetsch M.A., Greineder D.K., and Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA 277 (1997) 887-891
8. Barnes P.J., Pedersen S., and Busse W.W. Efficacy and safety of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 159 (1999) 941
9. Williamson I.J., Matusiewicz S.P., Brown P.H., Greening A.P., and Crompton G.K. Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations. Eur Respir J 8 (1995) 590-592
10. Efthimiou J., and Barnes P.J. Effect of inhaled corticosteroids on bones and growth. Eur Respir J 11 (1998) 1167-1177
11. Adams N.P., Bestall J.C., and Jones P. Beclomethasone at different doses for chronic asthma. Cochrane Database Syst Rev 4 (1999) CD002879
12. Adams N.P., Bestall J.C., and Jones P. Budesonide at different doses for chronic asthma. Cochrane Database Syst Rev 2 (2000) CD003271
13. Adams N.P., Bestall J.C., Jones P., Lasserson T.J., Griffiths B., and Cates C.J. Fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Syst Rev 4 (2008) CD003534
14. Castle W., Fuller R., Hall J., and Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 306 (1993) 1034-1037
15. Nelson H.S., Weiss S.T., Bleeker E.R., Yancey S.W., Dorinsky P.M., and the Smart Study Group. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129 (2006) 15-26
16. Ni Chroinin M., Greenstone I.I.G., and Ducharme F. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults. Cochrane Database Syst Rev 4 (2004) CD005307
17. Ni Chroinin M., Greenstone I.I.G., Ducharme F., Masse V., and Danish A. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Cochrane Database Syst Rev 4 (2005) CD005535
18. Salpeter S.R., Buckley N.S., Ormiston T.M., and Salpeter E.E. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med 144 (2006) 904-912
19. Ernst P., McIvor A., Ducharme F.M., Boulet L.-P., FitzGerald J.M., Chapman K.R., Bai T.R., et al. Safety and effectiveness of long acting inhaled B- agonist bronchodilators when taken with inhaled corticosteroids. Ann Intern Med 145 (2006) 692-694
20. Bateman E., Nelson H., Bousquet J., Kral K., Sutton L., Ortega H., et al. Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events. Ann Intern Med 149 (2008) 33-42
21. Jaeschke R., O'Byrne P.M., Mejza F., Nair P., Leśniak W., Broek J., et al. The safety of long-acting β-agonists among patients with asthma using inhaled corticosteroids. systematic review and meta-analysis. Am J Respir Crit Care Med 178 (2008) 1009-1016
22. Sears M.R. Safety of long-acting β-agonists: are new data really required?. Chest 136 (2009) 604-607
23. Wijesinghe M., Weatherall M., Perrin K., Harwood M., and Beasley R. Risk of mortality associated with formoterol: a systematic review and meta-analysis. Eur Respir J 34 (2009) 803-811
24. Kramer J.M. Balancing the benefits and risks of inhaled long-acting beta agonists-the influence of values. N Engl J Med 360 (2009) 1592-1595
25. Cheung D., Timmers M.C., Zwinderman A.H., Bel E.H., Dijkman J.H., and Sterk P.J. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyper-responsiveness in patients with mild asthma. N Engl J Med 327 (1992) 1198-1203
26. Ducharme F., Lasserson T.J., and Cates C.J. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev 4 (2006) CD003137
27. Weinberger M., and Hendeles L. Theophylline in asthma. N Engl J Med 334 (1996) 1380-1388
28. Evans D.J., Taylor D.A., Zetterstrom O., Chung K.F., O'Connor B.J., and Barnes P.J. A comparison of low-dose inhaled budesonide plus theophylline and high dose inhaled budesonide for moderate asthma. N Engl J Med 337 (1997) 1412-1418
29. Brumbak R.A., Wilson H., and Slalon R.D. Behavioral problems in children taking theophylline. Lancet 1 (1984) 958
30. Furukawa C.T., Shapiro G.G., Bierman C.W., Kraemer M.J., Ward D.J., and Pierson W.F. A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma. Pediatrics 74 (1984) 453-459
31. Springer C., Goldenberg B., and Godfrey S. Clinical, physiologic and psychologic comparison of treatment by cromolyn or theophylline in childhood asthma. J Allergy Clin Immunol 76 (1985) 64-69
32. Yurdakul A.S., Calisir H.C., Tunctan B., and Ogretensoy M. Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma. Respir Med 96 (2002) 322-329
33. Bateman E.D., Hurd S.S., Barnes P.J., Bousquet J., Drazen J.M., FitzGerald J.M., et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31 (2008) 143-178
34. FitzGerald J.M., and Gibson P. Asthma exacerbations: prevention. Thorax 61 (2006) 992-999